{"id":"NCT00877877","sponsor":"GlaxoSmithKline","briefTitle":"Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.","officialTitle":"Follow-up Study to Evaluate the Long-term Immunogenicity and Safety of a HPV Vaccine (GSK 580299) in Healthy Female Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05-07","primaryCompletion":"2015-01-06","completion":"2015-01-06","firstPosted":"2009-04-08","resultsPosted":"2011-04-27","lastUpdate":"2020-01-18"},"enrollment":632,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus","Papillomavirus Vaccines"],"interventions":[{"type":"PROCEDURE","name":"Blood sampling","otherNames":[]}],"arms":[{"label":"Cervarix Group","type":"OTHER"}],"summary":"Infection with human papillomavirus (HPV) has been clearly established as the necessary cause of cervical cancer. This study is designed to evaluate the long-term immunogenicity and safety of the 580299 HPV vaccine up to 10 years after administration of the first dose of HPV vaccine (Month 0) administered in the primary study 580299/013. This protocol posting deals with objectives \\& outcome measures of the extension phase from Month 60 to Month 120. The objectives \\& outcome measures of the primary phase are presented in a separate protocol posting (NCT00196924). The objectives \\& outcome measures of the extension phase up to Month 48 are presented in a separate protocol posting (NCT00316706).","primaryOutcome":{"measure":"Number of Seroconverted Subjects With Anti-HPV-16/18 Antibody Titers Equal to or Above Cut-off Values.","timeFrame":"At Month 60","effectByArm":[{"arm":"Cervarix Group","deltaMin":353,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":26,"countries":["Colombia","Germany","Honduras","Panama","Taiwan"]},"refs":{"pmids":["24978856","31268383"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":397},"commonTop":[]}}